21 -5 (91) 2026 - Azimov S.I. - PERSONALIZED TREATMENT METHOD FOR PATIENTS WITH CHRONIC NON-SPECIFIC UPPER URINARY TRACT INFECTIONS

PERSONALIZED TREATMENT METHOD FOR PATIENTS WITH CHRONIC NON-SPECIFIC UPPER URINARY TRACT INFECTIONS

Azimov S.I. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The personalized LDA treatment method we developed allows for differentiated treatment strategies for patients with chronic upper urinary tract infections (CUTIs), taking into account the clinical and immunological phenotype of the disease and its severity. This enables the use of a basic or enhanced therapeutic strategy aimed at correcting the underlying immunopathogenetic mechanisms of the inflammatory process.

Keywords: upper urinary tract infections, personalized treatment method, immunological phenotypes.

First page

126

Last page

131

For citation:Azimov S.I. - PERSONALIZED TREATMENT METHOD FOR PATIENTS WITH CHRONIC NON-SPECIFIC UPPER URINARY TRACT INFECTIONS//New Day in Medicine 5(91)2026 126-131 https://newdayworldmedicine.com/en/new_day_medicine/5-91-2026

List of References

  1. Berdichevskiy BA, Zubik GV, Latypov TI, Krupinkina DB. Birlamchi surunkali pielonefrit misolida surunkali buyrak kasalligining molekulyar-hujayra bosqichi situ (uchuvchi tadqiqot). Ural universiteti tibbiyoti. 2025;11(1):17-19.
  2. Ershova KA, Shindyapina NV, Kuligin AV. Urosepsis rivojlanishini bashorat qilish: bashorat qiluvchilar, usullar, texnologiyalar. Anesteziologiya va reanimatsiya byulleteni. 2025;22(6):107-116.
  3. Ivanov VA, Manozirova DI. Surunkali pielonefrit. Tibbiyot va ta'limdagi integrativ tendentsiyalar. 2025;2:47-52.
  4. Larina VN, Kudina EV, Sheregova EN, и др. Poliklinika shifokori amaliyotida surunkali pielonefrit va surunkali buyrak kasalligi. Москва: ГЭОТАР-Медиа; 2023. 144 с. ISBN 978-5-9704-7717-5.
  5. Mambetova SJ, Samigullina AE. Urodinamik buzilishlar bilan kechadigan homiladorlik pielonefritining patofiziologik jihatlari (adabiyotlar sharhi). Qirg'izistonning fan, yangi texnologiyalari va innovatsiyalari. 2020;(12):46-51.
  6. Xodjiev RD. Erkaklarda siydik yo'llari infektsiyalari: diagnostika, davolash va oldini olish. Akademik jurnalistika. 2025;(12-1):694-697.
  7. Abuelshayeb L, Abu-Farha R, Hammour KA, Zawiah M. Carbapenem de-escalation in urinary tract infections: prevalence and outcomes among hospitalized patients. BMC Infect Dis. 2025;25(1):562.
  8. Assefa M, Tigabie M, Amare A, et al. Global prevalence and etiologies of urinary tract infection among oncology patients: a systematic review and meta-analysis. World J Urol. 2025;43(1):389.
  9. Ghali H, Saad OKB, Bhiri S, et al. Epidemiology and risk factors of healthcare-associated urinary tract infections: a prospective study in a Tunisian tertiary hospital. Sci Rep. 2025;15(1):29948.
  10. Gilbert NM, Ramirez Hernandez LA, Berman D, et al. Social, microbial, and immune factors linking bacterial vaginosis and infectious disease. J Clin Invest. 2025;135(11):e184322.

    file

    download